A category thesis that reached investors before the deck did
We turned a private strategy into a public thesis about where the category is going. Funds began tracking the company between rounds, and the raise started from inbound interest rather than a cold list.
- 11
- inbound investor conversations
- 3
- term sheet discussions
- 0
- cold outreach to funds
Good traction, a clear plan, and a founder who was invisible between funding rounds. Every raise restarted the relationship building from nothing.
We published the category thesis in public, in the founder's own voice, with the operating detail investors rarely get to see. It ran steadily for months before the raise opened.
Funds tracked the company between rounds, eleven investor conversations arrived inbound, and three progressed to term sheet discussions without any cold approach.
- A stated view on where the category is going, defended publicly.
- Operating detail shared openly instead of held for the data room.
- A short list of funds followed and engaged with over months.
- Founder profile written for investors and clinical buyers at once.
Clinicians nodded politely and never replied. Nine months later, four health systems opened the conversation themselves.
Every deal that moved had started with someone who already knew them. So we made far more people know them.
The company had clinical credibility sitting in one person. Nobody outside the building could see it.